Advertisement

P-450 Cytochromes in the Human Placenta: Oxidations of Xenobiotics and Endogenous Steroids

A Review
  • Mont R. Juchau
  • Moses J. Namkung
  • Allan E. Rettie
Chapter
Part of the Trophoblast Research book series (TR)

Abstract

The purpose of this article is to provide the reader with a concise view of current concepts concerning the family of P-450 hemoproteins as they exist and function in the human placenta. The subject is discussed with focus on the monooxygenation of small, foreign organic molecules (xenobiotics) in placental tissues and cells, and of the relationships of these monooxygenation reactions to placental P-450-dependent oxidations of endogenous steroids. Several past reviews of placental biotransformation of xenobiotics have appeared in the open literature and references to these are provided for readers more seriously interested in this highly specialized topic. The first review of this research area appeared in 1969 (Juchau and Yaffe, 1969). A very comprehensive and detailed review of the earlier literature appeared in 1973 (Juchau, 1973). A more recent, comprehensive, and readily accessible review appeared in 1980 (Juchau, 1980) and the latest review is in press at the time of this writing (Juchau and Rettie, 1985). Dr. Olvai Pelkonen of Finland has actively researched this area and has also provided relatively recent reviews (Pelkonen, 1980; Pelkonen and Pasanen, 1984). Other reviews appearing between 1969 and 1985 are referenced in those cited above.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alin, P., Mannervik, B., and Jornvall, H. (1985) Structural evidence for three different types of gluathione transferase in human tissues. FEBS Lett. 182, 319–322.PubMedGoogle Scholar
  2. Anderson, C.M. and Mendelson, C.R. (1985) Regulation of steroidogenesis in rat leydig cells in culture: Effect of human choronic gonadotropin and dibutyryl cyclic AMP on the synthesis of cholesterol side-chain cleavage cytochrome P450 and adrenodoxin. Arch. Biochem. Biophys. 238, 378–387.PubMedGoogle Scholar
  3. Astrom, A. and DePierre, J.W. (1985) Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. Carcinogenesis. 6, 113–120.PubMedGoogle Scholar
  4. Awasthi, Y.C. and Singh, S.V. (1984) Purification and characterization of a new form of glutathione-S-transferase from human erythrocytes. Biochem. Biophys. Res. Comm. 1265, 1053–1060.Google Scholar
  5. Bellino, F.L. and Hussa, R.O. (1978) Trophoblast estrogen synthetase stimulation by dibutyryl cyclic AMP and theophylline: Increase in cytochrome P-450 content. Biochem. Biophys Res. Comm. 85, 1588–595.PubMedGoogle Scholar
  6. Bellino, F.L. and Hussa, R.O. (1985) Estrogen synthetase stimulation by hemin in human choriocarcinoma cell culture. Biochem. Biophys. Res. Comm. 127, 232–238.PubMedGoogle Scholar
  7. Black, S.D. and Coon, M.J. (1985) Studies on the identity of the heme-binding cysteinyl residue in rabbit liver microsomal cytochrome P-450 isozyme 2. Biochem. Biophys. Res. Comm. 128, 82–89.PubMedGoogle Scholar
  8. Bond, J.A., Omiecinski, C.J., and Juchau, M.R. (1979) Kinetics, activation and induction of aortic monooxygenases: Anlysis of the mixed-function oxidation of benzo(a)pyrene with high-pressure liquid chromatography. Biochem. Pharmacol. 28, 305–312.PubMedGoogle Scholar
  9. Bond, J.A., Yang, H.L., Majesky, M.W., Benditt, E.P., and Juchau, M.R. (1980) Metabolism of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene in chicken aortas: Monooxygenation, bioactivation to mutagens and covalent binding to DNA in vitro. Toxicol. Appl. Pharmacol. 52, 323–335.PubMedGoogle Scholar
  10. Burns, B. and Gurtner, G.H. (1973) A specific carrier for oxygen and carbon monoxide in the lung and placenta. Drug Metab. Disp. 1, 374–387.Google Scholar
  11. Canick, J.A. and Ryan, K.J. (1978) Properties of the aromatase system associated with the mitochondrial fraction of human placenta. Steroids 32, 499–509.PubMedGoogle Scholar
  12. Cedard, L., Alsat, E., Urtasun, M., and Varnagot, J. (1970) Studies on the mode of action of luteinizing hormone and chronic gonadotropin on estrogenic biosynthesis and glycogenolysis by human placental perfused in vitro. Steroids 16, 361–375.Google Scholar
  13. Chakraborty, J., Hopkins, R., and Parke, D.V. (1972) Inhibition studies on the aromatization of androst-4-ene-3,17-dione by human placental microsomal preparations. Biochem. J. 130, 19 P.Google Scholar
  14. Chao, S.J. and Juchau, M.R. (1980) Interaction of endogenous and exogenous estrogenic compounds with human placental microsomal cytochrome P-450 (P-450hpm). J. Ster. Biochem. 13, 127–133.Google Scholar
  15. Chao, S.T., Omiecinski, C.J., Namkung, M.J., Nelson, S.D., Dvorchick, B.H., and Juchau, M.R. (1981) Catechol estrogen formation in placental and fetal tissues of humans, macaques, rats and rabbits. Dev. Pharmacol. Ther. 2, 1–17.PubMedGoogle Scholar
  16. Conney, A.H., Welch, R., Kuntzman, R., Poland, A., Poppers, P.J., Finster, M., Wolfe, J.A., Munro-Faure, A.D., Peck, A.W., Bye, A., Chang, R., and Jacobson, M. (1971) Effects of environmental chemicals on the metabolism of drugs, carcinogens and normal body constituents in man. Ann. NY Acad. Sci. 179, 155–167.PubMedGoogle Scholar
  17. Dean, P.A., Namkung, M.J., and Juchau, M.R. (1984) Potentiation of hematinmediated increases in pulmonary monooxygenase activity cytosolic protein. Toxicologist 4, 388.Google Scholar
  18. Dee, A., Carlson, G., Smith, C., Masters, B.S., and Waterman, M.R. (1985) Regulation of synthesis and activity of bovine adrenocortical NADPH-cytochrome P-450 reductase by ACTH. Biochem. Biophys. Res. Comm. 128, 650–656.PubMedGoogle Scholar
  19. Frauenfelder, H. and Wolynes, P.G. (1985) Rate theories and puzzles of hemeprotein kinetics. Sci. 229, 337–345.Google Scholar
  20. Fujino, T., Parks, S.S., West, D., and Gelboin, H.V. (1982) Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79, 3682–3686.PubMedGoogle Scholar
  21. Fujino, T., Gottleib, K., Manchester, D.K., Park, S.S., West, D., Gurtoo, H.L., Tarone, R.E., and Gelboin, H.V. (1984) Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Can. Res. 44, 3916–3923.Google Scholar
  22. Gelboin, H.V., West, D., Gozukara, E., Natori, S., Nagao, M., and Sugimura, T. (1981) Maackiain acetate specifically inhibits different forms of aryl hydrocarbon hydroxylase in rat and man. Nature 291, 659–661.PubMedGoogle Scholar
  23. Gilbert, R.D., Cummings, L.A., Juchau, M.R., and Longo, L.D. (1979) Placental diffusing capacity and fetal development in exercising or hypoxic guinea pigs. J. Appl. Physiol. 46, 828–835.PubMedGoogle Scholar
  24. Gonzales, F.J., Kimura, S., and Nebert, D.W. (1985) Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1–450 and P3–450 genes. J. Biol. Chem. 260, 5040–5049.Google Scholar
  25. Greim, H. (1970) Synthesesteigerung und Abbauhemmung bei der Vermehrung der mikrosomalen Cytochrome P-450 und b5 durch Phenobarbital. Naunyn Schmeideberg’s Archiv. fur Pharmakologie 266, 261–275.Google Scholar
  26. Gunasegarem, R., Peh, K.L., Loganath, A., Karim, S.M.M., and Ratnam, S.J. (1982) Inhibition of second trimester human placental cholesterol C-20, 22-desmolase activity by soluble constituents of cigarette smoke. IRCS Med. Sci. 10, 322323.Google Scholar
  27. Gurtner, G.H. and Burns, B. (1973) The role of cytochrome P-450 of placenta in facilitated oxygen diffusion. Drug Metab. Disp. 1, 368–374.Google Scholar
  28. Guthenberg, C. and Mannervik, B. (1981) Glutathione S-transferase (Transferase n) from erythrocytes. Biochim. Biophys. Acta 662, 255–261.Google Scholar
  29. Hodgson, E. and Juchau, M.R. (1977) Ligand binding to human placental cytochrome P-450: Interaction of steroids and heme-binding ligands. J. Ster. Biochem. 8, 669–675.Google Scholar
  30. Huang, M., Johnson, E.F., Muller-Eberhard, U., Koop, D.R., Coon, M.J., and Conney, A.H. (1981) Specificity in the activation and inhibition by flavonoids of benzo(a)pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes. J. Biol. Chem. 256, 10897–10901.PubMedGoogle Scholar
  31. Juchau, M.R., Krasner, J., and Yaffe, S.J. (1968) Studies on reduction of azo linkages in human placental homogenates. Biochem. Pharmacol. 17, 1969–1979.PubMedGoogle Scholar
  32. Jaiswal, A.K., Gonzales, F.J., and Nebert, D.W. (1985) Human dioxin-inducible cytochrome P1–450: Complementary DNA and amino acid sequence. Sci. 228, 80–82.Google Scholar
  33. Jellinck, P.H., Hahn, E.F., Norton, B.I., and Fishman, J. (1984) Catechol estrogen formation and metabolism in brain tissue: Comparison of tritium release from different positions in ring A of the steroid. Endocrinol. 115, 1850–1856.Google Scholar
  34. John, M.E., John, M.C., Simpson, E.R., and Waterman, M.R. (1985) Regulation of cytochrome P-450118 gene expression by adrenocorticotropin. J. Biol. Chem. 260, 5710–5767.Google Scholar
  35. Juchau, M.R. (1969) Studies on the reduction of aromatic nitro groups in human and rodent placental homogenates. J. Pharmacol. Exp. Ther. 165, 1–8.PubMedGoogle Scholar
  36. Juchau, M.R. (1971) Human placental hydroxylation of 3,4-benzopyrene during early gestation and at term. Toxicol. Appl. Pharmacol. 18, 665–675.PubMedGoogle Scholar
  37. Juchau, M.R. (1973) Placental metabolism in relation to toxicology. CRC Crit. Rev. Toxicol. 2, 125–159.PubMedGoogle Scholar
  38. Juchau, M.R. (1980) Drug biotransformation in the placenta. Pharmacol. Ther. 8, 501–524.PubMedGoogle Scholar
  39. Juchau, M.R. (1984) Placental drug metabolism with respect to transplacental carcinogenesis. In: Comparative Perinatal Carcinogenesis, (ed.), H.M. Schuller, CRC Press, Inc., Boca Raton, Florida, pp. 117–137.Google Scholar
  40. Juchau, M.R. and Yaffe, S.J. (1969) Biotransformations of drug substrates in placental homogenates. In: The Foeto-Placental Unit, (eds.), A. Pecile and C. Finzi, Amsterdam, Excerpta Medica Foundation, pp. 269–270.Google Scholar
  41. Juchau, M.R. and Symms, K.G. (1972) Aniline hydroxylation in the human placenta–mechanistic aspects. Biochem. Pharmacol. 21, 2053–2065.PubMedGoogle Scholar
  42. Juchau, M.R., Lee, Q.H., and Blake, P.H. (1972) Inverse correlation between aryl hydrocarbon hydroxylase activity and conversion of cholesterol to pregnenolone in human placentas at term. Life Sci. II: Biochem. Gen. Molec. Biol. 11, 949–956.Google Scholar
  43. Juchau, M.R. and Smuckler, E.A. (1973) Subcellular localization of human placental aryl hydrocarbon hydroxylase. Toxicol. Appl. Pharmacol. 126, 163–180.Google Scholar
  44. Juchau, M.R., Zachariah, P.K., Colson, J., Symmns, K.G., Krasner, J., and Yaffe, S.J. (1974) Studies on human placental carbon monoxide-binding cytochromes. Drug Metab. Disp. 2, 79–86.Google Scholar
  45. Juchau, M.R. and Namkung, M.J. (1974) Studies on the biotransformation of naphthalene-1,2-oxide in fetal and placental tissues of humans and monkeys. Drug Metab. Disp. 2, 380–386.Google Scholar
  46. Juchau, M.R. and Zachariah, P.K. (1975a) Displacement of carbon monoxide from placental cytochrome P-450 by steroids: Antagonistic effects of androstenedione and 19-norandrostenedione. Biochem. Biophys. Res. Comm. 65, 1026–1032.PubMedGoogle Scholar
  47. Juchau, M.R. and Zachariah, P.K. (1975b) Comparative studies on the oxidation and reduction of drug substrates in human placental versus rat hepatic microsomes. Biochem. Pharmacol. 24, 227–233.PubMedGoogle Scholar
  48. Juchau, M.R., Namkung, M.J., Berry, D.L., and Zachariah, P.K. (1975) Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys: Correlations with aryl hydrocarbon hydroxylase activities. Drug Metab. Disp. 3, 494–502.Google Scholar
  49. Juchau, M.R., Mirkin, D.L., and Zachariah, P.K. (1976) Interactions of various 19norsteroids with human placental microsomal cytochrome P-450 (P- 4 50hpm)• Chem. Bio. Interactions. 15, 337–347.Google Scholar
  50. Juchau, M.R., Namkung, M.J., Jones, A.H., and DiGiovanni, J. (1978) Biotransformation and bioactivation of 7,12-dimethylbenz(a)anthracene in human fetal and placental tissues. Drug Metab. Disp. 6, 273–281.Google Scholar
  51. Juchau, M.R., Namkung, M.J., and Chao, S.T. (1982) Monoxygenase induction in the human placenta: Interrelationships among position-specific hydroxylation of 17f3-estradiol and benzo(a)pyrene. Drug Metab. Disp. 10, 220–225.Google Scholar
  52. Juchau, M.R., Omiecinski, C.J., and Namkung, M.J. (1982) Hematin-mediated increases in P-450-dependent monooxygenation reactions: An apparent short-term regulatory mechanism. In: Microsomes, Drug Oxidations and Drug Toxicities, (eds.), R. Sato and R. Kato ), Wiley-Interscience, New York, pp. 371–381.Google Scholar
  53. Juchau, M.R. and Rettie, A.E. (1985) The metabolic role of the placenta. In: Principles of Drug and Chemical Action in Pregnancy,(eds.), S.E. Fabro and A.R. Scialli, Marcel Dekker, Inc., New York, in press.Google Scholar
  54. Kaelin, A.C. and Cummings, A.J. (1983) A study of monooxygenase activity in human placental homogenates: In vitro behavior towards a number of substrates and inhibitors. Biochem. Pharmacol. 32, 2421–2426.PubMedGoogle Scholar
  55. Kaelin, A.C. and Cummings, A.J. (1984) Differential inhibition of human placental monooxygenase activity: Evidence for multiple forms of 7-ethoxycoumarin Odeethylase. Biochem. Pharmacol. 33, 505–508.PubMedGoogle Scholar
  56. Koop, D.R., Crump, B.L., Nordblom, G.D., and Coon, M.J. (1985) Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroerthylene, acetone, pyrazole and isoniazid. Proc. Natl. Acad. Sci. USA 82, 4065–4069.PubMedGoogle Scholar
  57. Lee, Q.P., Zachariah, P.K., and Juchau, M.R. (1975) Differential inhibition of androst4-en-3,17-dione aromatization by carbon monoxide in the presence of estr-4-en3,17-dione. Steroids 26, 571–579.PubMedGoogle Scholar
  58. Levin, W., Thomas, P.E., Reik, L.M., Ryan, D.E., Bandiera, S., Haniu, M., and Shively, J.E. (1985) Immunochemical and structural characterization of rat hepatic cytochromes P-450. In: Microsomes and Drug Oxidations, (eds.), A.R. Boobis et al., Taylor and Francis, London, pp. 13–23.Google Scholar
  59. Lin, T. (1985) Mechanism of action of gonadotropin-releasing hormone stimulated Leydig cell steroidogenesis III. The role of arachidonic acid and calcium/phospholipid dependent protein kinase. Life Sci. 1255–1264.Google Scholar
  60. Manchester, D.K. and Jacoby, E.H. (1982a) Resolution and reconstitution of human placental monooxygenase activity responsive to maternal cigarette smoking. Dey. Pharmacol. Ther. 5, 162–172.Google Scholar
  61. Manchester, D.K. and Jacoby, E.H. (1982b) Glutathione S-transferase activities in placentas from smoking and nonsmoking women. Xenobiotica 12, 543–547.PubMedGoogle Scholar
  62. Marx, J.L. (1985) The cytochrome P-450’s and their genes. Sci. 228, 975–976.Google Scholar
  63. Meigs, R.A. and Moothry, K.B. (1984) The support of steroid aromatization by mitochondrial metabolic activities of the placenta. J. Ster. Biochem. 20, 883–886.Google Scholar
  64. Meigs, R.A. and Ryan, K.J. (1968) Cytochrome P-450 and steroid synthesis in the human placenta. Biochem. Biophys. Acta 165, 476–483.PubMedGoogle Scholar
  65. Meigs, R.A. and Ryan, K.J. (1971) Enzymatic aromatization of steroids. I. Effects of oxygen and carbon monoxide on the intermediate steps of estrogen biosynthesis. J. Biol. Chem. 239, 2370–2377.Google Scholar
  66. Morgan, E.T., MacGeoch, C., and Gustafsson, J. (1985) Sexual difference of cytochrome P-450 in rat liver: Evidence for a constitutive isozyme on the male-specific 16a-hydroxylase. Mol. Pharmacol. 27, 471–479.PubMedGoogle Scholar
  67. Namkung, M.J., Zachariah, P.K., and Juchau, M.R. (1977) 0-sulfonation of Nhydroxy-2-fluorenylacetamide and 7-hydroxy-N-2-fluorenylacetamide in fetal and placental tissues of humans and guinea pigs. Drug. Metab. Disp. 5, 288–294.Google Scholar
  68. Namkung, M.J., Chao, S.T., and Juchau, M.R. (1983) Placental monooxygenation: Characteristics and partial purification of a hematin-activated human placental monooxygenase. DrugMetab. Disp. 11, 10–15.Google Scholar
  69. Namkung, M.J., Faustman-Watts, E.M., and Juchau, M.R. (1983) Hematin-mediated increases in benzo(a)pyrene monooxygenation in maternal, fetal and placental tissues of inducible and non-inducible mouse strains. Del). Pharmacol. Ther. 6, 199–207.Google Scholar
  70. Namkung, M.J., Porubek, D.H., Nelson, S.D., and Juchau, M.R. (1985) Regulation of aromatic oxidation of estradiol-17f3 in maternal hepatic, fetal hepatic and placental tissues: Comparative effects of a series of inducing agents. J. Ster. Biochem. 22, 563–568.Google Scholar
  71. Nebert, D.W., Winker, J., and Gelboin, H.V. (1969) Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Canc. Res. 29, 1763–1769.Google Scholar
  72. Nebert, D.W. and Gonzales, F.J. (1985) Cytochrome P-450 gene expression and regulation. Trends Pharmacol. Sci. 6, 160–164.Google Scholar
  73. Omiecinski, C.J., Bond, J.A., and Juchau, M.R. (1978) Stimulation by hematin of monooxygenase activity in extra-hepatic tissues from rats, rabbits and chickens. Biochem. Biophys. Res. Comm. 83, 1004–1011.PubMedGoogle Scholar
  74. Omiecinski, C.J., Chao, S.T., and Juchau, M.R. (1980) Modulation of monooxygenase activities by hematin and 7,8-benzoflavone in fetal tissues of rats, rabbits, and humans. Dey. Pharmacol. Ther. 1, 90–100.Google Scholar
  75. Omiecinski, C.J., Namkung, M.J., and Juchau, M.R. (1980) Mechanistic aspects of the hematin-mediated increases in brain monooxygenase activities. Molec. Pharmacol. 17, 225–232.Google Scholar
  76. Omiecinski, C.J. and Juchau, M.R. (1980) Hematin-mediated increases in the monooxygenation of polynuclear aromatic hydrocarbons. Proc. West. Pharmacol. Soc. 23, 9–13.PubMedGoogle Scholar
  77. Omiecinski, C.J., Namkung, M.J., and Juchau, M.R. (1982) Substrate and position specifity of hematin-activated monooxygenation reactions. Biochem. Pharmacol. 30, 2837–2845.Google Scholar
  78. Omura, T. and Sato, R. (1964) The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein structure. J. Biol. Chem. 239, 2370–2377.PubMedGoogle Scholar
  79. Pelkonen, O. and Pasanen, M. (1984) Enzymology and regulation of xenobiotic and steroid metabolism in the placenta. Biochem. Soc. Trans. 12, 42–44.PubMedGoogle Scholar
  80. Park, S.S., Miller, H., Guengerich, P.F., and Gelboin, H.V. (1985) Monoclonal antibodies to liver microsomal pregnenolone-16a-carbonitrile induced cytochrome P-450E of rat liver. Pharmacologist 27, 114.Google Scholar
  81. Pasanen, M. (1984) Human placental aromatase activity: Use of a C-18 reversed phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and nonsmoking mothers in vitro. Biol. Res. Preg. 5, 1–6.Google Scholar
  82. Pasanen, M. and Pelkonen, O. (1981) Solubilization and purification of human placental cytochromes P-450. Biochem. Biophys. Res. Comm. 103, 1310–1317.PubMedGoogle Scholar
  83. Pasanen, M. and Pelkonen, O. (1984) Cholesterol side-chain cleavage activity in human placenta and bovine adrenals: A one-step method for separation of pregnenolone formed in vitro. Steroids 43, 517–527.PubMedGoogle Scholar
  84. Paul, S.M., Axelrod, J. and Diliberto, E.J. (1977) Catechol estrogen-forming enzyme of the brain: Demonstration of a cytochrome P-450 monooxygenase. Endocrinol. 101, 1604–1610.Google Scholar
  85. Pelkonen, O. (1980) Environmental influences on human foetal and placental xenobiotic metabolism. Eur. J. Clin. Pharmacol. 18, 17–24.PubMedGoogle Scholar
  86. Pelkonen, O. (1984) Xenobiotic metabolism in the maternal-placental-fetal unit: Implications for fetal toxicity. Deu. Pharmacol. Ther. 7, 11–17.Google Scholar
  87. Pelkonen, 0., Jouppila, P., and Karki, N.T. (1972) Effect of maternal cigarette smoking on 3,4-benzpyrene and N-methylaniline metabolism in human fetal liver and placenta. Toxicol. Appl. Pharmacol. 23, 399–406.Google Scholar
  88. Pelkonen, O. and Moilanen, M.L. (1979) The specificity and multiplicity of human placental xenobiotic-metabolizing monooxygenase systems studied by potential substrates, inhibitors and gel electrophoresis. Med. Biol. 57, 306–312.PubMedGoogle Scholar
  89. Philpot, R.M., Domin, B.A., Devereux, T.R., Harris, C., Anderson, M.W., Fouts, J.R, and Bend, J.R. (1985) Cytochrome P-450-dependent monooxygenase systems of the lung: Relationships to pulmonary toxicity. In: Microsomes and Drug Oxidations, (eds.), A.R. Boobis et al., Taylor and Francis, London, pp. 248–255.Google Scholar
  90. Polidoro, G., Dillio, C., Del Boccio, G., Zulli, P., and Federici, G. (1980) Glutathione Stransferase activity in human placenta. Biochem. Pharmacol. 29, 1677–681.PubMedGoogle Scholar
  91. Radulovic, L.L. and Kulkarni, A.P. (1985) A rapid, novel high performance liquid chromatography method for the purification of glutathione S-transferase: An application to the human placental enzyme. Biochem. Biophys. Res. Comm. 128, 75–81.PubMedGoogle Scholar
  92. Raucy, J.L. and Johnson, E.F. (1985) Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone. Molec. Pharmacol. 27, 296–301.Google Scholar
  93. Rettie, A.E., Heimark, L., Mayer, R.T., Burke, M.D., Trager, W.F., and Juchau, M.R. (1985) Stereoselective and regioselective hydroxylation of warfarin and selective 0-dealkylation of phenoxazone ethers in human placenta. Biochem. Biophys. Res. Comm. 126, 1012–1022.Google Scholar
  94. Ruckpaul, K., Rein, H., and Blanck, J. (1985) Regulation mechanisms of the endoplasmic cytochrome P-450 system of the liver. Biomed. Biochem. Acta 44, 351–380.Google Scholar
  95. Ryan, D.E., Dixon, R., Evans, R.H., Ramanthan, L., Thomas, P.E., Wood, A.W., and Levin, W. (1984) Rat hepatic cytochrome P-450 isozymes specifity for the metabolism of the steroid sulfate, 5a-androstane-3a,1713-diol-3,17-disulfate. Arch. Biochem. Biophys. 233, 636–642.PubMedGoogle Scholar
  96. Symms, K.G. and Juchau, M.R. (1972) Further studies on the catalysis of nitro group reduction in tissue-free systems. Proc. West. Pharmacol. Soc. 15, 156–161.Google Scholar
  97. Satoh, K., Kitahara, A., Soma, Y., Inaba, Y., Hatayama, I., and Sato, K. (1985) Purification, induction and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA 52, 3964–3968.Google Scholar
  98. Schwab, G.E. and Johnson, E.F. (1985) Variation in hepatic microsomal P-4501 concentration among untreated rabbits alters the efficiency of estradiol hydroxylation. Arch. Biochem. Biophys. 237, 17–26.PubMedGoogle Scholar
  99. Simpson, E.R. and Miller, D.A. (1978) Cholesterol side-chain cleavage, cytochrome P450 and iron sulfur protein in human placental mitochondria. Arch. Biochem. Biophys. 190, 800–808.PubMedGoogle Scholar
  100. Song, B., Gelboin, H.V., Park, S.S., Tsokos, G.C., and Friedman, F.K. (1985) Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes. Sci. 228, 490–492.Google Scholar
  101. Symms, K.G. and Juchau, M.R. (1973) Stablization, solubilization, partial purification and some properties of cytochrome P-450 present in Ca C12-precipitated human placental microsomes. Life Sci. 13, 1221–1230.Google Scholar
  102. Symms, K.G. and Juchau, M.R. (1974) The aniline hydroxylase and nitro-reductase activities of partially purified cytochromes P-450 and P-420 and cytochrome b5 solubilized from rabbit hepatic microsomes. Drug Metab. Disp. 2, 194–201.Google Scholar
  103. Thompson, E.A., Jr. and Siiteri, P.K. (1974) The involvement of human placental microsomal cytochrome P-450 in aromatization. J. Biol. Chem. 249, 5373–5378.PubMedGoogle Scholar
  104. Thompson, E.A., Jr. and Siiteri, P.K. (1979) Subcellular distribution of aromatase in human placenta and ovary. Horm. Res. 11, 179–185.PubMedGoogle Scholar
  105. Torminaga, T. and Toren, P. (1967) Stimulation of aromatization in human placenta by human placental lactogen. J. Clin. Invest. 46, 1124A.Google Scholar
  106. Tseng, L. and Bellino, F.L. (1983) Inhibition of aromatase and NADPH cytochrome c reductase activities in human endometrium by the human plcental NADPH cytochrome c reductase antiserum. J. Ster. Biochem. 22, 555–558.Google Scholar
  107. Tukey, R.H. and Nebert, D.W. (1984) Regulation of mouse cytochrome P3–450 by the Ah receptor. Studies with a P3–450 cDNA clone. Biochem. 23, 6003–6008.Google Scholar
  108. Virgo, B.B. and Vockentanz, B.M. (1985) Feminization of the hepatic monooxygenases by growth hormone is mimicked by puromycin and correlates with a decrease in male-type cytochrome P-450. Biochem. Biophys. Res. Comm. 128, 683–688.Google Scholar
  109. Washida, N., Matsui, S., and Osawa, Y. (1985) Preparation of monoclonal antibody against human placental aromatase II cytochrome P-450. Fed. Proc. 44, 861.Google Scholar
  110. Welch, R.M., Harrison, Y.E., Gomni, B.W., Poppers, P.J., Finster, M., and Conney, A.H. (1969) Stimulating effects of cigarette smoking on the hydroxylation of 3,4-benzpyrene and the N-demthylation of 3-methyl-4-monomethylaminoazobenzene by enzymes in human placentas. Clin. Pharmacol. Ther. 10, 100–115.PubMedGoogle Scholar
  111. Wrighton, S.A., Maurel, P., Schultz, E.G., Watkins, P.B., Young, B., and Guzelian, P.S. (1985) Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid-responsive cytochrome P-450g. Biochem. 24, 2171–2179.Google Scholar
  112. Wolf, A.S., Musch, K., Speidel, W., Strecker, J.R., and Lauritzen, C. (1978) Steroid metabolism in the perfused human placenta. I. Metabolism of dehydroepiandrosterone sulfate. Acta Endocrinol. (Kb) 87, 181–191.Google Scholar
  113. Zachariah, P.K. and Juchau, M.R. (1975) Interactions of steroids with human placental cytochrome P-450 in the presence of carbon moxoxide. Life Sci. 16, 1689–1693.PubMedGoogle Scholar
  114. Zachariah, P.K., Lee, Q.P., Symms, K.G., and Juchau, M.R. (1976) Further studies on the properties of human placental microsomal cytochrome P-450. Biochem. Pharm. 25, 793–800.PubMedGoogle Scholar
  115. Zachariah, P.K. and Juchau, M.R. (1977) Inhibition of human placental mixed-function oxidations with carbon monoxide: Reversal with monochromatic light. J. Ster. Biochem. 8, 221–228.Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Mont R. Juchau
    • 1
  • Moses J. Namkung
    • 1
  • Allan E. Rettie
    • 1
  1. 1.Department of Pharmacology School of Medicine SJ-30University of WashingtonSeattleUSA

Personalised recommendations